Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.81)
# 3,291
Out of 5,114 analysts
343
Total ratings
28.38%
Success rate
-8.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Maintains: Buy | $36 → $47 | $36.01 | +30.52% | 3 | Dec 19, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $28 → $32 | $21.98 | +45.59% | 7 | Dec 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $36 → $45 | $27.93 | +61.12% | 23 | Dec 11, 2025 | |
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $2.16 | +779.63% | 13 | Nov 25, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $51 | $49.08 | +3.91% | 13 | Nov 24, 2025 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $56 → $48 | $24.46 | +96.24% | 3 | Nov 20, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $12 → $15 | $4.74 | +216.46% | 2 | Nov 12, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $4.36 | +106.42% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.27 | +293.70% | 13 | Nov 6, 2025 | |
| VTYX Ventyx Biosciences | Upgrades: Buy | $18 | $8.74 | +105.95% | 16 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $42 | $12.84 | +227.10% | 19 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $72 | $33.81 | +112.95% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.20 | +900.00% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $30.98 | +93.67% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.66 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.44 | +568.60% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $8.95 | +346.93% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $11.59 | +201.98% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.86 | +829.04% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.99 | +125.56% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.86 | +975.27% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $11.38 | +216.34% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $63.96 | +79.80% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $7.92 | +3,435.35% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.27 | +252.42% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.20 | +614.29% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.79 | +905.59% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.75 | +4,769.60% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.73 | +857.46% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.33 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.70 | +2,469.59% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.71 | +4,564.31% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.26 | - | 1 | Apr 25, 2024 |
vTv Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $36 → $47
Current: $36.01
Upside: +30.52%
Arcus Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $28 → $32
Current: $21.98
Upside: +45.59%
Olema Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $36 → $45
Current: $27.93
Upside: +61.12%
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $2.16
Upside: +779.63%
AnaptysBio
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $49.08
Upside: +3.91%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Buy
Price Target: $56 → $48
Current: $24.46
Upside: +96.24%
Artiva Biotherapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $4.74
Upside: +216.46%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.36
Upside: +106.42%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.27
Upside: +293.70%
Ventyx Biosciences
Nov 5, 2025
Upgrades: Buy
Price Target: $18
Current: $8.74
Upside: +105.95%
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $12.84
Upside: +227.10%
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $33.81
Upside: +112.95%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $1.20
Upside: +900.00%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $30.98
Upside: +93.67%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.66
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $3.44
Upside: +568.60%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $8.95
Upside: +346.93%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $11.59
Upside: +201.98%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.86
Upside: +829.04%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.99
Upside: +125.56%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.86
Upside: +975.27%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $11.38
Upside: +216.34%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $63.96
Upside: +79.80%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $7.92
Upside: +3,435.35%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.27
Upside: +252.42%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.20
Upside: +614.29%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.79
Upside: +905.59%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.75
Upside: +4,769.60%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.73
Upside: +857.46%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.33
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $0.70
Upside: +2,469.59%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.71
Upside: +4,564.31%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.26
Upside: -